Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshihiro Nishimura

Showing results (1-10 of 237) with videos related to

Pageof 24
Sort By:
Nihon Hoshasen Gijutsu Gakkai Zasshi|July 13, 2007
[New approach to nuclear cardiology]Yoshihiro Nishimura
Infectious Diseases (London, England)|May 14, 2019
Viral pneumonia: which patients should we focus on?Naoko Katsurada, Yoshihiro Nishimura
Journal of Thoracic Disease|June 28, 2019
Who will suffer from hyperprogressive disease in patients with advanced non-small cell lung cancer treated with PD-1/PD-L1 inhibitorsMotoko Tachihara, Yoshihiro Nishimura
Bioscience, Biotechnology, and Biochemistry|March 24, 2005
Static suppression of tomato bacterial wilt by bacterial coagulation using a new functional polymer that coagulates bacterial cells and is highly biodegradableNariyoshi Kawabata, Wataru Sakakura, Yoshihiro Nishimura
In Vivo (Athens, Greece)|March 4, 2022
Retrospective Analysis of the Starting Dose of Combined ICS/LABA for Cough-variant Asthma and Cough-predominant AsthmaTakeo Nakajima, Tatsuya Nagano, Yoshihiro Nishimura
Kyobu Geka. the Japanese Journal of Thoracic Surgery|October 30, 2004
[An operative approach of extrapleural pneumonectomy]Yoshihiro Nishimura, S Fukai, T Hashizume
Molecules (Basel, Switzerland)|September 5, 2020
Novel Multitarget Therapies for Lung Cancer and Respiratory DiseaseMasako Yumura, Tatsuya Nagano, Yoshihiro Nishimura
Cells|November 18, 2018
Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment StrategyTatsuya Nagano, Motoko Tachihara, Yoshihiro Nishimura
The Kobe Journal of Medical Sciences|May 3, 2005
Imbalance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 is associated with pulmonary emphysema in Klotho miceYasuhiro Funada, Yoshihiro Nishimura, Mitsuhiro Yokoyama
Current Cancer Drug Targets|December 12, 2018
Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung CancerTatsuya Nagano, Motoko Tachihara, Yoshihiro Nishimura
Pageof 24

Showing results (1-10 of 237) with videos related to

Sort By:
Pageof 24
Nihon Hoshasen Gijutsu Gakkai Zasshi|July 13, 2007
[New approach to nuclear cardiology]Yoshihiro Nishimura
Infectious Diseases (London, England)|May 14, 2019
Viral pneumonia: which patients should we focus on?Naoko Katsurada, Yoshihiro Nishimura
Journal of Thoracic Disease|June 28, 2019
Who will suffer from hyperprogressive disease in patients with advanced non-small cell lung cancer treated with PD-1/PD-L1 inhibitorsMotoko Tachihara, Yoshihiro Nishimura
Bioscience, Biotechnology, and Biochemistry|March 24, 2005
Static suppression of tomato bacterial wilt by bacterial coagulation using a new functional polymer that coagulates bacterial cells and is highly biodegradableNariyoshi Kawabata, Wataru Sakakura, Yoshihiro Nishimura
In Vivo (Athens, Greece)|March 4, 2022
Retrospective Analysis of the Starting Dose of Combined ICS/LABA for Cough-variant Asthma and Cough-predominant AsthmaTakeo Nakajima, Tatsuya Nagano, Yoshihiro Nishimura
Kyobu Geka. the Japanese Journal of Thoracic Surgery|October 30, 2004
[An operative approach of extrapleural pneumonectomy]Yoshihiro Nishimura, S Fukai, T Hashizume
Molecules (Basel, Switzerland)|September 5, 2020
Novel Multitarget Therapies for Lung Cancer and Respiratory DiseaseMasako Yumura, Tatsuya Nagano, Yoshihiro Nishimura
Cells|November 18, 2018
Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment StrategyTatsuya Nagano, Motoko Tachihara, Yoshihiro Nishimura
The Kobe Journal of Medical Sciences|May 3, 2005
Imbalance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 is associated with pulmonary emphysema in Klotho miceYasuhiro Funada, Yoshihiro Nishimura, Mitsuhiro Yokoyama
Current Cancer Drug Targets|December 12, 2018
Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung CancerTatsuya Nagano, Motoko Tachihara, Yoshihiro Nishimura
Pageof 24